NasdaqGS - Delayed Quote • USD
Intuitive Surgical, Inc. (ISRG)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 7:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 26 | 24 |
| Avg. Estimate | 1.41 | 1.56 | 6.25 | 7.32 |
| Low Estimate | 1.3 | 1.45 | 5.96 | 6.76 |
| High Estimate | 1.54 | 1.67 | 6.76 | 8.34 |
| Year Ago EPS | 1.23 | 1.42 | 5.71 | 6.25 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 28 | 26 |
| Avg. Estimate | 1.87B | 1.98B | 8.01B | 9.24B |
| Low Estimate | 1.81B | 1.93B | 7.81B | 8.82B |
| High Estimate | 1.91B | 2.02B | 8.25B | 9.9B |
| Year Ago Sales | 1.6B | 1.74B | 7.12B | 8.01B |
| Sales Growth (year/est) | 17.10% | 13.80% | 12.40% | 15.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.2 | 1.33 | 1.41 | 1.48 |
| EPS Actual | 1.23 | 1.42 | 1.46 | 1.6 |
| Difference | 0.03 | 0.09 | 0.05 | 0.12 |
| Surprise % | 2.50% | 6.80% | 3.50% | 8.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.41 | 1.56 | 6.25 | 7.32 |
| 7 Days Ago | 1.41 | 1.56 | 6.25 | 7.32 |
| 30 Days Ago | 1.41 | 1.56 | 6.25 | 7.3 |
| 60 Days Ago | 1.41 | 1.56 | 6.25 | 7.32 |
| 90 Days Ago | 1.46 | 1.62 | 6.43 | 7.47 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ISRG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 14.60% | -- | -- | 0.80% |
| Next Qtr. | 9.90% | -- | -- | 9.60% |
| Current Year | 9.50% | -- | -- | 4.50% |
| Next Year | 17.10% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 12.36% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 10.21% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 4/8/2024 |
| Maintains | Citigroup: Buy to Buy | 4/3/2024 |
| Reiterates | Stifel: Buy to Buy | 3/15/2024 |
| Maintains | Mizuho: Neutral to Neutral | 1/25/2024 |
| Maintains | Barclays: Overweight to Overweight | 1/25/2024 |
| Maintains | Raymond James: Outperform to Outperform | 1/25/2024 |
Related Tickers
RMD ResMed Inc.
177.61
+2.17%
BDX Becton, Dickinson and Company
233.15
+0.40%
BAX Baxter International Inc.
39.65
+0.33%
WST West Pharmaceutical Services, Inc.
377.33
-0.01%
STAA STAAR Surgical Company
46.77
+0.93%
HOLX Hologic, Inc.
75.10
+0.24%
RGEN Repligen Corporation
157.06
-2.44%
OLYMY Olympus Corporation
14.17
0.00%
COO The Cooper Companies, Inc.
90.41
+0.61%
ALC Alcon Inc.
78.47
-0.67%